Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus

Clinica Chimica Acta

Volumn 326, Issue 1-2, 2002, Pages 105-112

  Agullo Ortuno M T ^a   Albaladejo, M D ^a   Parra, S ^a   Rodriguez Manotas M ^a   Fenollar, M ^a   Ruiz Espejo F ^a   Tebar, J ^a   Martinez P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Diabetes mellitus; Hyperhomocysteinaemia; Macroangiopathy; Nephropathy; Neuropathy; Retinopathy

Indexed keywords

BIOCHEMICAL MARKER; HOMOCYSTEINE; BIOLOGICAL MARKER;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEX DIFFERENCE; AGED; ANALYSIS OF VARIANCE; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0036889421     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00287-5     Document Type: Article

References (30)

1. Audelin M.C., Genest J. Jr. Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis. 159(2):2001;497-511.
2. Jensen T., Borch Johnsen K., Kofoed Enevoldsen A., Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 30:1987;144-148.
3. Knöbl P., Schernthaner G., Schnack C.et al. Thrombogenic factors are related to urinary albumin excretion in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36:1993;1045-1050.
4. Yeromenko Y., Lavie L., Levy Y. Homocysteine and cardiovascular risk in patients with diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 11(2):2001;108-116.
5. Mudd S.H., Levy H.L., Skovby F. Disorders of transulfuration. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disease. 7th Ed. 1995;1279-1327 McGraw-Hill, New York.
6. Rosenblatt D.S. Inherited disorders of folate transport and metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disease. 7th Ed. 1995;3111-3128 McGraw-Hill, New York.
7. Kang S.-S., Wong P.W.K. Genetic and nongenetic factors for moderate hyperhomocysteinemia. Atherosclerosis. 119:1996;135-138.
8. Bostom A.G., Shemin D., Lapane K.L.et al. Hyperhomocysteinaemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis. 114:1995;93-103.
9. Bostom A., Brosnan J.T., Hall B., Nadeau M.R., Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis. 116:1995;59-62.
10. Stampfer M.J., Malinow M.R. Can lowering homocysteine levels reduce cardiovascular risk? N. Engl. J. Med. 332:1995;328-329.
11. Huttberg B., Agardh E., Andersson A.et al. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 51:1991;277-282.
12. Munshi M.N., Stone A., Fink L., Fonseca V. Hyperhomocysteinaemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism. 45:1996;133-135.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care. 20(7):July 1997;1183-1197.
14. Friedewald W.T., Levy R.J., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
15. Andersson A., Brattström L., Israelsson B., Isaksson A., Hamfelt A., Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur. J. Clin. Invest. 22:1992;79-87.
16. Berg K., Malinow M.R., Kierulf P., Upson B. Population variation and genetic of plasma homocyst(e)ine level. Clin. Genet. 41:1992;315-321.
17. Jacobsen D.W., Gatautis V.J., Green R.et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate levels in normal subjects. Clin. Chem. 40:1994;873-881.
18. Bates C.J., Mansoor M.A., Van der Pols J., Prentice A., Cole T.J., Finch S. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and older. Eur. J. Clin. Nutr. 51:1997;691-697.
19. Jacques P., Rosenberg I., Rogers G.et al. Serum total homocysteine concentrations in adolescent and adult American: result from the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 69:1999;482-489.
20. Malinow M.R., Levenson J., Giral P.et al. Role of blood pressure, uric acid, and haemorrheological parameters on plasma homocysteine concentration. Atherosclerosis. 114:1995;175-183.
21. Nakata H., Horita K., Eto M. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications. Metabolism. 42(10):1993 (Oct.);1323-1326.
22. Buysschaert M., Jamart J., Dramais A.S., Wallemacq P., Hermans M.P. Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients. Diabetes Metab. 27(6):2001;655-659.
23. Lynn E.G., Chung Y.H., Siow Y.L., Man R.Y., Choy P.C. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim. Biophys. Acta. 1393(2-3):1998;317-324.
24. Chico A., Perez A., Cordoba A.et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 41:1998;684-693.
25. Hoogeveen E.K., Kostense P.J., Jakobs C.et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation. 101(13):2000 (Apr. 4);1506-1511.
26. Van Beynum I.M., Smeitink J.A.M., Den Heijer M.et al. A risk factor for ischemic cerebrovascular disease in children. Circulation. 99:1999;2070-2072.
27. Lussier-Cacan S., Xhignesse M., Piolot A., Selhub J., Davignon J., Genest J. Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am. J. Clin. Nutr. 64:1996;587-593.
28. Norlund L., Grubb A., Fex G.et al. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin. Chem. Lab. Med. 36(3):1998;175-178.
29. Robinson K., Gupta A., Dennis V.et al. Hyperhomocysteinemia confers an independent increased risk of atheroesclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation. 94:1996;2743-2748.
30. Gónzalez-Clemente J.M., Deulofeu R., Mitjavila J.et al. Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease. Diabetes Care. 25(3):2002;632-633.